Escalon Medical Corporation Revenue Quarterly YoY Growth:
14.28% for Dec. 31, 2012Escalon Medical Corporation Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 14.28% |
| Sept. 30, 2012 | -5.69% |
| June 30, 2012 | -6.35% |
| March 31, 2012 | -5.21% |
| Dec. 31, 2011 | -51.45% |
| Sept. 30, 2011 | -67.82% |
| June 30, 2011 | -19.05% |
| March 31, 2011 | -18.67% |
| Dec. 31, 2010 | -17.83% |
| Sept. 30, 2010 | -0.58% |
| June 30, 2010 | 69.50% |
| March 31, 2010 | -14.52% |
| Dec. 31, 2009 | -1.39% |
| Sept. 30, 2009 | -13.50% |
| June 30, 2009 | -38.02% |
| March 31, 2009 | 12.43% |
| Dec. 31, 2008 | 8.05% |
| Sept. 30, 2008 | 26.17% |
| June 30, 2008 | 2.15% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
ESMC Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| BSD Medical Corporation | 201.3% |
| Abiomed | 16.95% |
| Guided Therapeutics | 9.88% |
ESMC Revenue Quarterly YoY Growth Rankings
| Overall |
83rd percentile 1353 of 8002 |
| Sector |
73rd percentile 184 of 684 in Healthcare |
| Industry |
73rd percentile 25 of 93 in Medical Devices |
ESMC Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -67.82% | Sep 2011 |
| Maximum | 69.50% | Jun 2010 |
| Average | -6.71% |
